The emergence of novel psychoactive substances offers a unique scenario for researchers and policymakers alike. Among these, 2-FDCK has gained prominence as a potent dissociative agent with unknown pharmacological properties. Initial studies suggest that 2-FDCK may elicit comparable effects to other dissociatives, such as ketamine, but its precise